Press Releases Archives - Page 31 of 103 - Lupin

BSE 2449.35 NSE 2448.70

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2449.35 NSE 2448.70

Lupin Receives Approval from U.S. FDA for Rufinamide Tablets USP

August 18, 2022

Lupin Receives Approval from U.S. FDA for Meclizine Hydrochloride Tablets USP

August 12, 2022

Lupin Q1 FY2023 Results

Lupin Receives Approval from U.S. FDA for Azilsartan Medoxomil Tablets

Lupin Diagnostics Launches its First Reference Laboratory in Ranchi

Lupin Foundation is Transforming Communities and Lives in Bharatpur and Alwar

Lupin’s Somerset Manufacturing Plant Receives EIR from US FDA

Lupin Receives Approval from U.S. FDA for Paliperidone Extended-Release Tablets

Lupin Diagnostics Launches its First Regional Reference Laboratory in Patna

Lupin Receives Tentative Approval from U.S. FDA for Ivacaftor Tablets

1 2 … 30 31 32 … 102 103

Search

Hit enter to search or ESC to close